PRFX - PainReform Ltd Net earnings per share (EPS TTM)
PainReform Ltd. delegates production and testing to external contractors, creating a strong dependency on vendors. Net income per share over the last four quarters helps identify the real business trend, where the value of -5.29 shows the most recent figure. Investors are awaiting approval of the PRF-110 gel, relying on FDA support. The company's goal is to replace opioids with safe methods of prolonged pain relief.
Comprehensive metric breakdowns and analytics for PainReform Ltd (PRFX)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
- net income and valuation multiples indicators:
PRFX - Final Profit|Projected Future Earnings PainReform Ltd.|PRFX - Market Cap to Earnings|Forward P/E Multiple PainReform|PRFX - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PainReform Ltd.|PRFX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months PainReform|PRFX - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months painreform.com|PRFX - Net earnings per share growth this year|Expected earnings per share growth for next year PainReform Ltd.
Analysis of all company metrics:PainReform Ltd. (PRFX)
This metric is calculated as the ratio of total annual net income to the number of shares outstanding. The metric determines the actual earnings per share, neutralizing the impact of issuance. For PainReform Ltd. (PRFX), this calculation is critical when competing with behemoths in the hospital segment. Profit growth confirms the effectiveness of niche analgesic drugs. By analyzing the company's EPS TTM dynamics, an investor assesses the fundamental resilience of the business to market pressure.
Competitors of PainReform Ltd.
HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|GLPG (Galapagos N.V.) - Earnings per one share for the last 12 months|ANI Pharma - Net earnings per share (EPS TTM)|MNKD - Net earnings per share (EPS TTM)|AMPH: Net earnings per share (EPS TTM)|PCRX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Earnings per share for the last 12 months TBPH (Theravance Biopharma Inc)|Earnings per share for the last twelve months Aquestive Pharma (AQST)|SCPH (scpharmaceuticals.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|tonixpharma.com (TNXP) - Net earnings per one share for the last twelve months|SXT China - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months EPRX|BioHarvest (BHST) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Invizyne (EXOZ)|Earnings per share for the last twelve months Oramed|ENTX: Earnings per share for the trailing year|Earnings per share for the last twelve months MindWalk Holdings Inc. (HYFT)|Net earnings per share for the last 12 months ABVC BioPharma Inc. ABVC|Cumberland Pharma - Net earnings per share for the last 12 months|Earnings per share for the trailing year QNTM|FGEN - Earnings per share for the last twelve months|TELO: Earnings per share for the last twelve months|RANI (ranitherapeutics.com) - Net earnings per share for the last 12 months|SNYR: Earnings per share for the last four quarters|RLYB (Rallybio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LEXX (Lexaria)|Net earnings per share for the last 12 months PULM (Pulmatrix, Inc.)|Net earnings per share for the last four quarters ftzy.com.cn|Earnings per share for the last twelve months Aptorum Group APM|LYRA (Lyra Therapeutics Inc.) - Earnings per one share for the last 12 months|IBO - Earnings per share for the last twelve months|Earnings per share for the trailing year TNFA (TNF Pharmaceuticals)|YCBD: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months CYTO (Altamira Therapeutics Ltd.)|Net earnings per share for the last 12 months LIPO|Earnings per share for the last 12 months OPTN (OptiNose Inc)|Earnings per share for the last twelve months Pieris (PIRS)|PROC: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PTPI (Petros Pharmaceuticals)|Earnings per share for the trailing year QLI|ACELYRIN - Net earnings per share (EPS TTM)|TFFP - Net earnings per share (EPS TTM)
